06.13.24 -- Assassination By Implication? Interview With WuXi AppTec (Part 2)

Delve into the complexities of scaling decisions. We’ll offer insights from both biopharma developers and a CDMO. Learn about their mutual interest in achieving successful scale-up and gain valuable strategies for avoiding common pitfalls. You’ll also hear about Lonza’s facility investments and scaling expertise designed to help you find your optimal scale. Click here to learn more.

Variability is inherent to biologics manufacturing. The trick is to catch it quickly and prevent product quality drift. That’s where the new ICH Q14 comes in.

Review a modeling approach employing artificial neural networks combined with simulation-derived parameters plus viscosity data from 27 highly concentrated mAbs.

Discover how commercially available LNP reagent mix, GenVoy-ILM, is an accessible and easy-to-use LNP formulation that allows for rapid preclinical development of RNA vaccines.

CDMOs are playing a critical role in preparing for future pandemics. Learn how innovative strategies and flexible platforms are helping to ensure a swift and effective response plan.

Capacity constraints typically are accompanied by other challenges, including missed timelines, defect rates, and overall decreased satisfaction with companies’ bioprocessing CDMOs.

A CDMO with experience in protein variant characterization, CQA analytics, and patient-centric product development can ensure the safety and efficacy of your biotherapeutic.

As we balance the time-to-market and risk, we must anticipate changing needs for combination device development, highlighting the technological paradigm shift.

Learn how utilizing expert analytical testing services can unlock the potential of biosimilars and bring cost-effective treatments to market faster.

At Abzena, the leading CDMO + CRO for complex biologics and bioconjugates, our focus is on providing a de-risked and streamlined development pathway for our customers.

The TSL consists of a large environmental chamber equipped with a control system, calibrated sensors, and a validated data collection system with mechanical and hydraulic equipment that can simulate a customized distribution environment profile.

The BioProcess™ Modular System can be configured to meet specific downstream process demands. It has the accuracy and documentation required for use in GMP-regulated environments.